EDGAR Filing Documents for 0001193125-17-197059

Form 8-K - Current report:

SEC Accession No. 0001193125-17-197059

Filing Date

2017-06-07

Accepted

2017-06-07 16:12:20

Documents

Period of Report

2017-06-06

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d392466d8k.htm	8-K	21008
2	EX-10.1	d392466dex101.htm	EX-10.1	269680
3	EX-99.1	d392466dex991.htm	EX-99.1	12207
4	GRAPHIC	g392466g42h63.jpg	GRAPHIC	4390
	Complete submission text file	0001193125-17-197059.txt		310690

Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628

Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020

ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)